Page last updated: 2024-10-28

hexamethonium and Hypertension, Pulmonary

hexamethonium has been researched along with Hypertension, Pulmonary in 3 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WILSON, VH1
KEELEY, KJ1
YU, PN1
NYE, RE1
LOVEJOY, FW1
SCHREINER, BF1
YIM, BJ1
SANCETTA, SM1

Other Studies

3 other studies available for hexamethonium and Hypertension, Pulmonary

ArticleYear
The haemodynamic effects of hexamethonium bromide in patients with pulmonary hypertension and heart failure.
    The South African journal of medical sciences, 1953, Volume: 18, Issue:3-4

    Topics: Blood Circulation; Heart Failure; Hemodynamics; Hexamethonium; Hypertension; Hypertension, Pulmonary

1953
Studies of pulmonary hypertension. IX. The effects of intravenous hexamethonium on pulmonary circulation in patients with mitral stenosis.
    The Journal of clinical investigation, 1958, Volume: 37, Issue:2

    Topics: Blood Circulation; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension, Pulmonary; Mitral V

1958
Acute hemodynamic effects of hexamethonium (C6) in patients with emphysematous pulmonary hypertension.
    American heart journal, 1955, Volume: 49, Issue:4

    Topics: Emphysema; Hemodynamics; Hexamethonium; Humans; Hypertension; Hypertension, Pulmonary; Muscle Relaxa

1955